Vivaldi Capital Management LP Novartis Ag Transaction History

Vivaldi Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $207,006 - $228,109	-2,420 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $182,468 - $224,576	2,420 New	2,420 $221,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $240,496 - $275,076	-3,193 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $235,196 - $261,889	3,193 New	3,193 $274,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Vivaldi Capital Management LP with notifications on news.